ConductScience.org, home

Paper31258685

Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.

Zhao J and 2 others. Exp Ther Med, 2019. Cited by 6 papers, by iCite. Retracted.

Cite this record

ConductScience Library. Reduced miR-202 levels enhanced oral cancer development via targeting Sp1. Papers, record 31258685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31258685

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.
PubMed
Journal
Exp Ther Med
PubMed
Year
2019
PubMed
Publication types
Journal Article, Retracted Publication
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.27
iCite
Retracted
Yes, by PubMed's record
PubMed
Revised in PubMed
2024-04-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao JJia
2Ding DDeguang
3Zhao GGe

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Retracted by38682115[Retracted] Reduced miR‑202 levels enhanced oral cancer development via targeting Sp1.https://conductscience.org/library/papers/38682115

Source PubMed

Download CSV of comments and corrections

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111846609Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods2001https://conductscience.org/library/papers/11846609PubMed
223731011MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer.Oral Dis2014https://conductscience.org/library/papers/23731011PubMed
324669014GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.Ann Oncol2014https://conductscience.org/library/papers/24669014PubMed
425500095miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer.Oral Oncol2015https://conductscience.org/library/papers/25500095PubMed
526879838Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.J Formos Med Assoc2017https://conductscience.org/library/papers/26879838PubMed
627235675Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.J Pathol2016https://conductscience.org/library/papers/27235675PubMed
727581787Micronome revealed miR-19a/b as key regulator of SOCS3 during cancer related inflammation of oral squamous cell carcinoma.Gene2016https://conductscience.org/library/papers/27581787PubMed
828077301MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma.Exp Cell Res2017https://conductscience.org/library/papers/28077301PubMed
928095864MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.Mol Cancer2017https://conductscience.org/library/papers/28095864PubMed
1028117748Decreased Sp1 Expression Mediates Downregulation of SHIP2 in Gastric Cancer Cells.Int J Mol Sci2017https://conductscience.org/library/papers/28117748PubMed
1128146434Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes.Oncotarget2017https://conductscience.org/library/papers/28146434PubMed
1228225083Antitumorigenic effect of atmospheric-pressure dielectric barrier discharge on human colorectal cancer cells via regulation of Sp1 transcription factor.Sci Rep2017https://conductscience.org/library/papers/28225083PubMed
1328290615MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5.Genet Mol Res2017https://conductscience.org/library/papers/28290615PubMed
1428484232Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer.Sci Rep2017https://conductscience.org/library/papers/28484232PubMed
1528529241Downregulation of Transcription Factor Sp1 Suppresses Malignant Properties of A549 Human Lung Cancer Cell Line with Decreased β4-Galactosylation of Highly Branched N-Glycans.Biol Pharm Bull2017https://conductscience.org/library/papers/28529241PubMed
1628569779Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer.Cell Death Dis2017https://conductscience.org/library/papers/28569779PubMed
1728846829RhoGDIβ promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation.Mol Oncol2017https://conductscience.org/library/papers/28846829PubMed
1828887525MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition.Sci Rep2017https://conductscience.org/library/papers/28887525PubMed
1929048658Functional diversity of miR-146a-5p and TRAF6 in normal and oral cancer cells.Int J Oncol2017https://conductscience.org/library/papers/29048658PubMed
2029048687SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab‑resistant ovarian cancer model.Oncol Rep2017https://conductscience.org/library/papers/29048687PubMed

See all 26 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
35682549The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.Int J Mol Sci2022https://conductscience.org/library/papers/35682549PubMed
34042273Reduced serum miR-202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein.Kaohsiung J Med Sci2021https://conductscience.org/library/papers/34042273PubMed
33344262Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.Front Cell Infect Microbiol2020https://conductscience.org/library/papers/33344262PubMed
33125090MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway.Int J Mol Med2020https://conductscience.org/library/papers/33125090PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
MIR202574448PubTator's text mininghttps://conductscience.org/library/genes/574448NCBI Gene
PTK2B2185PubTator's text mininghttps://conductscience.org/library/genes/2185NCBI Gene
SP16667PubTator's text mininghttps://conductscience.org/library/genes/6667NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31258685

GET https://conductscience.org/api/papers/v1/31258685/references?page=2